The influence of metformin and empagliflozin administration on gut microbiota in individuals with type 2 diabetes mellitus and hypothyroidism
K.A. Moskva,
O.P. Kikhtyak,
T.A. Kikhtiak
et al.
Abstract:Background. There is a lack of studies focusing on the combined impact of metformin, empagliflozin, and levothyroxine on the gut microbiota in patients with type 2 diabetes mellitus (T2DM) and hypothyroidism. The purpose of the study was to examine how the combination of metformin and empagliflozin affects gut microbiota composition in patients with type 2 diabetes and hypothyroidism. Materials and methods. We enrolled 47 patients who have been receiving hormone replacement therapy with levothyroxine at a stab… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.